✦ LIBER ✦

Efficacy and Safety of a Potent and Selective Peroxisome Proliferator Activated Receptor Alpha Agonist in Subjects With Dyslipidemia and Type 2 Diabetes Mellitus

✍ Scribed by Steven G. Terra; Omar L. Francone; Charles F. Contant; Xiang Gao; Andrew J. Lewin; Tu T. Nguyen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peroxisome proliferator–activated recept

✍ Jie Yu; Nan Jin; Guang Wang; Fuchun Zhang; Jieming Mao; Xian Wang 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Association of peroxisome proliferator-a

✍ Ying Yang; Xingbo Mo; Shufeng Chen; Xiangfeng Lu; Dongfeng Gu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB

Common polymorphisms of the peroxisome p

✍ Ming-Chia Hsieh; Kun-Der Lin; Kai-Jen Tien; Shih-Te Tu; Jeng-Yueh Hsiao; Shun-Je 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Discovery of a Novel Series of Peroxisom

✍ Liu, Kun; Xu, Libo; Berger, Joel P.; MacNaul, Karen L.; Zhou, Gauchao; Doebber, 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 98 KB

Genetic polymorphisms in peroxisome prol

✍ M. K. Moon; Y. M. Cho; H. S. Jung; Y. J. Park; K. H. Yoon; Y. A. Sung; B. L. Par 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Putative association of peroxisome proli

✍ K. S. Park; H. D. Shin; B. L. Park; H. S. Cheong; Y. M. Cho; H. K. Lee; J.-Y. Le 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB